Status:
UNKNOWN
The ACCT2 Study Individuals With Type 2 Diabetes and Non-Western Backgrounds (ACCT2)
Lead Sponsor:
Steno Diabetes Center Copenhagen
Conditions:
Type 2 Diabetes
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The overall purpose of the present study is to examine the effect of implementing a 12-month person-centred and culturally sensitive intervention on glycaemic control in individuals with type 2 diabet...
Detailed Description
Individuals with a non-Western background have a higher prevalence of T2D and exhibit poorer glycaemic control (HbA1c levels) than those with Danish ethnic background. Research indicates that individu...
Eligibility Criteria
Inclusion
- Having T2D with poor glycaemic control (HbA1c ≥53 mmol/mol) and where individual treatment goal for HbA1c has not been achieved (in two consecutive measurements)
- Having a non-Western background speaking either Urdu, Arabic or Turkish as native language
- Already in a course of treatment at the outpatient T2D clinic at SDCC
Exclusion
- Age: \> 75 years
- Residing part-time in Denmark
- Marker of kidney function - estimated glomerular filtration rate (eGFR) below 30 mL/min
- Having severe mental disorders
- Having disabilities inhibiting physical attendance
- Participant's general condition contraindicates continuing the study, as judged by the investigator or a medical expert
- Participant's withdrawal of the informed consent
Key Trial Info
Start Date :
November 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06147245
Start Date
November 9 2023
End Date
December 31 2025
Last Update
December 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Steno Diabetes Center Copenhagen
Herlev, Denmark, 2730